17-78902983-C-A
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001243540.2(CEP295NL):c.-99+151G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.514 in 152,090 control chromosomes in the GnomAD database, including 20,937 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.51 ( 20937 hom., cov: 33)
Consequence
CEP295NL
NM_001243540.2 intron
NM_001243540.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.05
Publications
12 publications found
Genes affected
CEP295NL (HGNC:44659): (CEP295 N-terminal like) Predicted to enable microtubule binding activity. Predicted to be involved in regulation of centriole replication. Predicted to be located in motile cilium. Predicted to be active in centriole; centrosome; and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TIMP2 (HGNC:11821): (TIMP metallopeptidase inhibitor 2) This gene is a member of the TIMP gene family. The proteins encoded by this gene family are natural inhibitors of the matrix metalloproteinases, a group of peptidases involved in degradation of the extracellular matrix. In addition to an inhibitory role against metalloproteinases, the encoded protein has a unique role among TIMP family members in its ability to directly suppress the proliferation of endothelial cells. As a result, the encoded protein may be critical to the maintenance of tissue homeostasis by suppressing the proliferation of quiescent tissues in response to angiogenic factors, and by inhibiting protease activity in tissues undergoing remodelling of the extracellular matrix. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.703 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CEP295NL | NM_001243540.2 | c.-99+151G>T | intron_variant | Intron 1 of 2 | ENST00000322630.3 | NP_001230469.1 | ||
| TIMP2 | NM_003255.5 | c.130+21976G>T | intron_variant | Intron 1 of 4 | ENST00000262768.11 | NP_003246.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CEP295NL | ENST00000322630.3 | c.-99+151G>T | intron_variant | Intron 1 of 2 | 2 | NM_001243540.2 | ENSP00000312767.2 | |||
| TIMP2 | ENST00000262768.11 | c.130+21976G>T | intron_variant | Intron 1 of 4 | 1 | NM_003255.5 | ENSP00000262768.6 |
Frequencies
GnomAD3 genomes AF: 0.514 AC: 78164AN: 151972Hom.: 20925 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
78164
AN:
151972
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.514 AC: 78210AN: 152090Hom.: 20937 Cov.: 33 AF XY: 0.511 AC XY: 38022AN XY: 74358 show subpopulations
GnomAD4 genome
AF:
AC:
78210
AN:
152090
Hom.:
Cov.:
33
AF XY:
AC XY:
38022
AN XY:
74358
show subpopulations
African (AFR)
AF:
AC:
15026
AN:
41482
American (AMR)
AF:
AC:
8820
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
1898
AN:
3472
East Asian (EAS)
AF:
AC:
3727
AN:
5156
South Asian (SAS)
AF:
AC:
2853
AN:
4818
European-Finnish (FIN)
AF:
AC:
5026
AN:
10590
Middle Eastern (MID)
AF:
AC:
150
AN:
294
European-Non Finnish (NFE)
AF:
AC:
39028
AN:
67968
Other (OTH)
AF:
AC:
1112
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1914
3828
5741
7655
9569
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
702
1404
2106
2808
3510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2257
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.